Oncology Archives

Poster

Exploring a possible relationship of germline CDKN2A mutations with breast cancer in a multi-gene panel cohort

Oncology

Date:

Friday, Jun 2, 2017 12:00pm – 1:05am

Conference:

ASCO 2017

Authors:

Holly Laduca, Amal Yussuf, Laura Panos, DJ Horcasitas, Ginger Chisholm, JR Chavez, AC Fontaine

Abstract

Presentation

Evaluation of a multi-gene panel test for inherited paragangliomas and pheochromocytomas. Is it time to re-assess guidelines for genetic testing?

Oncology

Speakers:

Carolyn Horton, Michelle Jackson, Amal Yussuf, Rachel McFarland, Kory Jasperson, Holly LaDuca

Conference:

—

Friday, Apr 1, 2016 3:00pm – 5:00pm

Abstract Presentation

Presentation

Breast and ovarian cancer risks beyond BRCA1/2 from a cohort of 15,000 women undergoing multigene panel testing

Oncology

Speakers:

Jill Dolinsky, Fergus J. Couch, David E. Goldgar, Steven N. Hart, Emily Hallberg, Raymond Moore, Huong Meeks, Robert Huether, Holly LaDuca, Elizabeth C. Chao

Conference:

BRCA Symposium 2016

Tuesday, May 10, 2016 3:00pm – 5:25pm

Abstract

Presentation

MSH6 and PMS2 Mutation Carriers Ascertained Through Multi-gene Panel Testing May Present With a Hereditary Breast and Ovarian Cancer Phenotype.

Oncology

Speakers:

Holly LaDuca, Carin Espenshied, Shuwei Li, Rachel McFarland, Chia-Ling Gau, Heather Hampel

Conference:

—

Wednesday, Jun 8, 2016 1:00pm – 3:15pm

Abstract

Presentation

BRCA2 mutation carriers may present with primary brain tumors: A review of a multigene panel testing cohort

Oncology

Speakers:

Michelle Jackson, Amanda Bergner

Conference:

NSGC 2016

Friday, Sep 30, 2016 10:30am – 10:45am

Abstract

Presentation

MSH6 and PMS2 carriers identified by multi-gene testing may have a breast-ovarian cancer phenotype

Oncology

Speakers:

Holly LaDuca, Carin Espenshied, Shuwei Li, Rachel McFarland, Chia-Ling Gau, Heather Hampel

Conference:

CGA-IGC 2016

Sunday, Oct 2, 2016 1:30pm – 3:00pm

Abstract

Presentation

Breast and colorectal cancer risk in monoallelic MUTYH carriers ascertained via multi-gene panel testing

Oncology

Speakers:

Kelly Fulk, Holly LaDuca, Carin Espenshied, Dajun Qian, Yuan Tian, Amal Yussuf, Kory Jasperson

Conference:

CGA-IGC 2016

Sunday, Oct 2, 2016 10:30am – 11:30am

Abstract

Presentation

Cancer risks associated with predisposition gene mutations identified by hereditary cancer panel testing of 85,000 patients

Oncology

Speakers:

Fergus J. Couch, Carin Espenshied, Rachel McFarland, Tina Pesaran, Holly LaDuca, Jill Dolinsky, Robert Huether

Conference:

ASHG 2016

Wednesday, Oct 19, 2016 9:00am – 9:15am

Collaborators:

Mayo Clinic

Abstract

Presentation

Breast cancer risks associated with mutations in cancer predisposition genes identified by clinical genetic testing of 50,000 breast cancer patients

Oncology

Speakers:

Fergus J. Couch, Robina Smith, Melissa Pronold, Robert Huether, Carin Espenshied, Shuwei Li, Tina Pesaran, Rachel McFarland, Holly LaDuca, Jill Dolinsky

Conference:

—

Wednesday, Dec 7, 2016 3:15pm – 5:00pm

Collaborators:

Mayo Clinic

Abstract

Poster

Prospective Registry of Multiplex Testing (PROMPT): a web-based platform to assess cancer risk of genetic variants.

Oncology

Date:

Friday, Jun 3, 2016 3:00pm – 6:00pm

Conference:

ASCO 2016

Authors:

Jill Dolinsky, Fergus Couch, Michael Francis Walsh, Pragna Gaddam, Laura Digiovanni, Judith Balmaña, Taylor Sittler, Rachel Klein, Stephen E Lincoln, Brian Allen, Justin Leighton, Charles Strom, Vanessa Ranger-Miller, Kyle Brown, Judy Ellen Garber, Susan M. Domchek, Mark E. Robson, Kenneth Offit

Abstract

Oncology

Exploring a possible relationship of germline CDKN2A mutations with breast cancer in a multi-gene panel cohort

Evaluation of a multi-gene panel test for inherited paragangliomas and pheochromocytomas. Is it time to re-assess guidelines for genetic testing?

Breast and ovarian cancer risks beyond BRCA1/2 from a cohort of 15,000 women undergoing multigene panel testing

MSH6 and PMS2 Mutation Carriers Ascertained Through Multi-gene Panel Testing May Present With a Hereditary Breast and Ovarian Cancer Phenotype.

BRCA2 mutation carriers may present with primary brain tumors: A review of a multigene panel testing cohort

MSH6 and PMS2 carriers identified by multi-gene testing may have a breast-ovarian cancer phenotype

Breast and colorectal cancer risk in monoallelic MUTYH carriers ascertained via multi-gene panel testing

Cancer risks associated with predisposition gene mutations identified by hereditary cancer panel testing of 85,000 patients

Breast cancer risks associated with mutations in cancer predisposition genes identified by clinical genetic testing of 50,000 breast cancer patients

Prospective Registry of Multiplex Testing (PROMPT): a web-based platform to assess cancer risk of genetic variants.

Patients

PROVIDERS

Solutions

Resources

Company

NOTICES

Oncology

Get in Touch